Form 4 ELI LILLY & Co For: Apr 15 Filed by: Hedley Mary Lynne

Go back to Form 4 ELI LILLY & Co For: Apr 15 Filed by: Hedley Mary Lynne

Eli Lilly (LLY) sleep apnea study data seen as a win, stock gains

April 17, 2024 11:12 AM EDT

Eli Lilly & Co. (NYSE: LLY) announced positive topline results from its SURMOUNT-OSA Ph3 study on Wednesday, which evaluated tirzepatide compared to placebo in patients with obesity and sleep apnea.

According to the company, the phase 3 clinical trials that showed tirzepatide injection significantly reduced the... More